| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(96)80144-9 |
| P698 | PubMed publication ID | 8773914 |
| P50 | author | Kenneth Fleming | Q46098555 |
| P2093 | author name string | R Chapman | |
| D Bansi | |||
| P2860 | cites work | Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis | Q29619714 |
| Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro | Q33605284 | ||
| Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood? | Q34375536 | ||
| Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. | Q34376222 | ||
| Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis | Q34395299 | ||
| Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. | Q34396552 | ||
| Sclerosing cholangitis and biliary tract calculi--primary or secondary? | Q34396560 | ||
| Role of immune factors in the pathogenesis of primary sclerosing cholangitis | Q37755860 | ||
| Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis | Q39630344 | ||
| A 39 year old man with chronic hepatitis | Q40664216 | ||
| ANCA and associated diseases: immunodiagnostic and pathogenetic aspects | Q40868442 | ||
| Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis | Q44663102 | ||
| A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease | Q46520994 | ||
| Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis | Q67553678 | ||
| Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis | Q67705022 | ||
| Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases | Q70588163 | ||
| Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis | Q72358295 | ||
| P433 | issue | 5 | |
| P921 | main subject | chronic liver disease | Q5113984 |
| P304 | page(s) | 581-586 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass | |
| P478 | volume | 24 |
| Q42266922 | A case of IgG4-related sclerosing disease complicated by sclerosing cholangitis, retroperitoneal fibrosis and orbital pseudotumour |
| Q77609403 | Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features |
| Q34796025 | Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"? |
| Q38497449 | Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis |
| Q35541984 | Autoantibodies in the Diagnosis and Management of Liver Disease |
| Q37970311 | Autoantibody-Negative Autoimmune Hepatitis |
| Q34210614 | Autoimmune cholangiopathy |
| Q37182946 | Clinical features and management of primary sclerosing cholangitis |
| Q73876496 | Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases |
| Q37885803 | Cryptogenic chronic hepatitis and its changing guise in adults |
| Q44700797 | Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance |
| Q28076505 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions |
| Q92166689 | Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases |
| Q42369219 | Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis |
| Q39436336 | Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis |
| Q27021715 | Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies |
| Q27478109 | IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis |
| Q42265292 | Liver failure unmasks celiac disease in a child |
| Q34310808 | Primary biliary cirrhosis and autoimmune cholangiopathy |
| Q79866264 | Primary sclerosing cholangitis |
| Q81781641 | Primary sclerosing cholangitis |
| Q93938179 | Primary sclerosing cholangitis |
| Q26774539 | Recurrence of autoimmune liver diseases after liver transplantation |
| Q36119478 | Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases |
| Q53237682 | The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. |
| Q83905675 | The immunobiology of primary sclerosing cholangitis |
Search more.